NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Enfamil NeuroPro Study
Enfamil NeuroPro Study

NCT06059209

Active Not RecruitingNA

Sponsor: University of Arizona

Conditions: Infant Development, Infant ALL

Interventions: Enfamil NeuroPro, Enfamil Infant

Countries: United States

This study will compare infant gut bacteria for infants who have been fed a standard infant formula (Enfamil Infant); infants who have been fed a new infant formula designed to be more similar to breast milk (Enfamil NeuroPro); and breastfed infants. These formulas are currently available on the market and meet FDA requirements for infant formula.

Eligibility overview

Sex: ALL

Age: 0 Months to 4 Months

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Healthy term infants with parental consent
* Parents are able to provide informed consent; own a smart phone and are able to fill out weekly digital questionnaires.

Exclusion Criteria:

* Prematurity (\<= 36 weeks gestational age)
* Babies born through c-section
* Any health issues identified at the first postpartum screening
* Use of both breast milk and formula
* Use of donor breast milk
* Parent unwillingness/inability to avoid giving prebiotics, probiotics, symbiotics, and immune-stimulating products to the child for the duration of this study
Locations (1)
  • Tucson, Arizona, United States